136 related articles for article (PubMed ID: 35119579)
21. Diagnostic validity of bone metabolic markers for bone metastasis.
Miura H; Yamamoto I; Takada M; Kigami Y; Ohta T; Yuu I; Hamanaka Y; Matsushita R; Morita R
Endocr J; 1997 Oct; 44(5):751-7. PubMed ID: 9466334
[TBL] [Abstract][Full Text] [Related]
22. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
23. Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma?
Staudenherz A; Steiner B; Puig S; Kainberger F; Leitha T
Cancer; 1999 Jan; 85(1):153-5. PubMed ID: 9921987
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Jung K; Lein M; Ringsdorf M; Roigas J; Schnorr D; Loening SA; Staack A
J Urol; 2006 Oct; 176(4 Pt 1):1326-31. PubMed ID: 16952623
[TBL] [Abstract][Full Text] [Related]
25. Improved classifications of planar whole-body bone scans using a computer-assisted diagnosis system: a multicenter, multiple-reader, multiple-case study.
Sadik M; Suurkula M; Höglund P; Järund A; Edenbrandt L
J Nucl Med; 2009 Mar; 50(3):368-75. PubMed ID: 19223423
[TBL] [Abstract][Full Text] [Related]
26. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of a computer-aided diagnosis system for whole-body bone scintigraphy to detect bone metastasis in breast cancer patients.
Urano M; Maki Y; Nishikawa H; Kawai T; Shiraki N; Shibamoto Y
Ann Nucl Med; 2017 Jan; 31(1):40-45. PubMed ID: 27686468
[TBL] [Abstract][Full Text] [Related]
28. Bone metabolic markers in the evaluation of bone scan flare phenomenon in bone metastases of breast cancer.
Koizumi M; Matsumoto S; Takahashi S; Yamashita T; Ogata E
Clin Nucl Med; 1999 Jan; 24(1):15-20. PubMed ID: 9890487
[TBL] [Abstract][Full Text] [Related]
29. Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
Watanabe S; Nakajima K; Mizokami A; Yaegashi H; Noguchi N; Kawashiri S; Inokuchi M; Kinuya S
Ann Nucl Med; 2017 Apr; 31(3):201-210. PubMed ID: 27995542
[TBL] [Abstract][Full Text] [Related]
30. CADBOSS: A computer-aided diagnosis system for whole-body bone scintigraphy scans.
Aslantas A; Dandil E; Saǧlam S; Çakiroǧlu M
J Cancer Res Ther; 2016; 12(2):787-92. PubMed ID: 27461652
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of routine bone scintigraphy renal imaging in renal cell carcinoma.
Chancellor MB; Konnak JW; Grossman HB
Urology; 1989 May; 33(5):440-2. PubMed ID: 2775373
[TBL] [Abstract][Full Text] [Related]
32. Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma.
Seaman E; Goluboff ET; Ross S; Sawczuk IS
Urology; 1996 Nov; 48(5):692-5. PubMed ID: 8911510
[TBL] [Abstract][Full Text] [Related]
33. [Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients].
Bednarek-Skublewska A; Chrapko B; Ksiazek A
Pol Arch Med Wewn; 2003 Sep; 110(3):943-50. PubMed ID: 14699686
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
[TBL] [Abstract][Full Text] [Related]
35. Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report.
Shimozuma K; Sonoo H; Fukunaga M; Ichihara K; Aoyama T; Tanaka K
Jpn J Clin Oncol; 1999 Jan; 29(1):16-22. PubMed ID: 10073146
[TBL] [Abstract][Full Text] [Related]
36. Textural differences between renal cell carcinoma subtypes: Machine learning-based quantitative computed tomography texture analysis with independent external validation.
Kocak B; Yardimci AH; Bektas CT; Turkcanoglu MH; Erdim C; Yucetas U; Koca SB; Kilickesmez O
Eur J Radiol; 2018 Oct; 107():149-157. PubMed ID: 30292260
[TBL] [Abstract][Full Text] [Related]
37. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
[TBL] [Abstract][Full Text] [Related]
38. Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.
Aktas B; Kasimir-Bauer S; Lehmann N; Kimmig R; Tewes M
Oncol Rep; 2013 Jul; 30(1):441-7. PubMed ID: 23604361
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach.
Hötker AM; Mazaheri Y; Wibmer A; Karlo CA; Zheng J; Moskowitz CS; Tickoo SK; Russo P; Hricak H; Akin O
AJR Am J Roentgenol; 2017 Mar; 208(3):W85-W91. PubMed ID: 28095036
[TBL] [Abstract][Full Text] [Related]
40. Thoracic Temporal Subtraction Three Dimensional Computed Tomography (3D-CT): Screening for Vertebral Metastases of Primary Lung Cancers.
Iwano S; Ito R; Umakoshi H; Karino T; Inoue T; Li Y; Naganawa S
PLoS One; 2017; 12(1):e0170309. PubMed ID: 28095493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]